In 1996, NARSAD Distinguished Investigator Grantee, David Shaffer, M.D. demonstrated that mental illness, along with other factors, such as substance abuse and prior suicide attempts, are major causes of teen suicide. His...
25 Years of Breakthroughs
David Shaffer, M.D.
February 02, 2012
E. Jane Costello, Ph.D.
February 01, 2012
Beginning in 1992, a longitudinal investigation known as the Great Smoky Mountain Study was conducted with approximately 1,400 children ages 9 - 16. The study, lead by NARSAD Distinguished Investigator Grantee, E. Jane...
David A. Brent, M.D.
January 30, 2012
In 1988, NARSAD Distinguished Investigator Grantee, David A. Brent, M.D. made significant discoveries leading to the identification of risk factors for youth suicide. Until his research in the late 1980s, the media...
Karl Deisseroth, M.D., Ph.D.
January 27, 2012
Optogenetics, a new technology invented by Karl Deisseroth, M.D., Ph.D., in 2005 with the help of a NARSAD Young Investigator Grant, gives researchers extraordinary control over specific brain circuits — and with it, new...
Herbert Y. Meltzer, M.D.
January 27, 2012
In 1989 NARSAD Distinguished Investigator and Foundation Scientific Council member, Herbert Y. Meltzer, M.D., proved that the drug Clozapine(tm) can be used on patients with severe treatment-resistant schizophrenia....
Pages
- « first
- ‹ previous
- 1
- 2
- 3
- 4
